Rapt therapeutics stock news trial#
Rapt therapeutics stock news download#

This website is for information purposes only. We cannot guarantee the success of any investment you make based on the information published here. RAPT is currently trading at 16.61, down 13.86 or 45.49, on the Nasdaq. The company was founded in 2015 and is headquartered in South San Francisco, CA. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases. The shares were sold at an average price of 35.69, for a total transaction of 94,507.12. Brockstedt sold 2,648 shares of the stock in a transaction dated Thursday, November 11th. A Look Into Healthcare Sector Value Stocks Benzinga Insights. However, the companys third-quarter loss was wider than Wall Streets estimates. operates as a clinical stage immunology-based biopharmaceutical company. (NASDAQ:RAPT) Insider Sells 94,507.12 in Stock. RAPT Therapeutics 13G Filing From Perceptive Advisors Shows New 5.4 Stake In Co.

Rapt therapeutics stock news trial#

This worrisome indicator is a canary in the coal mine for stock-market tops MarketWatch. The company reported positive initial data from an ongoing Phase 1/2 trial of FLX475 in multiple cancer indications. With the help of past performance, such developments are subject to a multitude of different influences. RAPT Therapeutics started at overweight with 61 stock price target at J.P. Our mathematical models are a tool to try to explore the possibility for future price development Or the tax implications an investment may have for the investor. Experience and risk profile of an individual investor Our forecasts cannot reflect the specific situation. Investments require additional considerations. That may be relevant for future security price flows. Securities and Exchange Commission on Wednesday showed that Ho sold 3,000 shares of Rapt Therapeutics at a price of 36. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or What Happened: A Form 4 filing from the U.S. We do not investigate the issuers of the securities to which our forecasts relate, nor do we considerР”Р„ny financial data or other data of such issuers with the exception of the past prices of the securities. If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and Information about these prices is provided to us by third parties.

Which are exclusively based on the prices of these securities in the past. The website offers price forecasts and analysis tools for equities and other securities, Get the latest Rapt Therapeutics Inc (RAPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Our forecast model is based on mathematical, statistical methods. The forecast (dashed curve) of the share price performance is based on historical data. The information can be used for day trading.

Rapt therapeutics stock news download#

You can export / download forecasted data as CSV file, no login required. On our site we made daily predictions for finance products based on statistical analysis.